Search Results - "Dhanushkodi, Manikandan"

Treatment options for patients with brain metastatic disease in HER2-positive breast cancer by Dhanushkodi, Manikandan

Get full text

Trastuzumab: A milestone in human epidermal growth factor receptor 2-positive breast cancer by Dhanushkodi, Manikandan

“…Human epidermal growth factor receptor 2 (HER2) overexpression is seen in 25% of breast cancers. Patients with HER2-positive breast cancer have aggressive…”
Get full text

Trastuzumab deruxtecan: A quantum leap in HER2-positive breast cancer by Dhanushkodi, Manikandan

“…Docetaxel, trastuzumab, and pertuzumab, known as THP, is the preferred first-line treatment for HER2-positive advanced breast cancer, and the second-line drug…”
Get full text

High-dose methotrexate by Dhanushkodi, Manikandan

“…High-dose methotrexate (HDMTX) is defined as methotrexate dose of ≥500 mg/m2. It is used in the treatment of acute lymphoblastic leukemia, osteosarcoma, and…”
Get full text

Olanzapine: The game-changer "antiemetic" by Dhanushkodi, Manikandan

“…Chemotherapy-induced nausea and vomiting (CINV) is significantly debilitating and worsens the quality of life. Olanzapine, an atypical antipsychotic drug, also…”
Get full text

Novel coronavirus severe acute respiratory syndrome-coronavirus 2 (coronavirus disease 2019): We shall overcome by Kulkarni, Padmaj, Dhanushkodi, Manikandan

“…[5] High-Risk Patients High-risk patients include elderly (>60 years); pregnant women; patients with renal failure, cancer, uncontrolled diabetes or…”
Get full text

COVID-19 management: What we need to know? by Dhanushkodi, Manikandan, Kulkarni, Padmaj

Get full text

Outcomes with chemotherapy in carcinoma penis: Experience from a tertiary cancer center by Mailankody, Sharada, Radhakrishnan, Venkatraman, Raja, Anand, Ganesan, Trivadi, Dhanushkodi, Manikandan, Sagar, Tenali

“…Background: Carcinoma penis is more common in India compared to the West. The role of chemotherapy in carcinoma penis is ambiguous. We analyzed the profile and…”
Get full text

Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy–induced vomiting in children: An open‐label, randomized phase 3 trial by Radhakrishnan, Venkatraman, Pai, Vishwajeeth, Rajaraman, Swaminathan, Mehra, Nikita, Ganesan, Trivadi, Dhanushkodi, Manikandan, Perumal Kalaiyarasi, Jayachandran, Rajan, Arun Kumar, Selvarajan, Gangothri, Ranganathan, Rama, Karunakaran, Parathan, Sagar, Tenali G.

“…Background Breakthrough chemotherapy–induced vomiting (CIV) is defined as CIV occurring after adequate antiemetic prophylaxis. Olanzapine and metoclopramide…”
Get full text

Metastatic nasopharyngeal carcinoma: Outcome from Cancer Institute, Chennai by Kumar, Arun, Kumar, Harish, Dhanushkodi, Manikandan, Ganesharajah, Selvaluxmy

“…Background: Optimal management of metastatic nasopharyngeal carcinoma (NPC) at presentation is debatable. The aim of this study was to investigate the…”
Get full text

Intravenous fosaprepitant for the prevention of chemotherapy‐induced vomiting in children: A double‐blind, placebo‐controlled, phase III randomized trial by Radhakrishnan, Venkatraman, Joshi, Archit, Ramamoorthy, Jaikumar, Rajaraman, Swaminathan, Ganesan, Prasanth, Ganesan, Trivadi S., Dhanushkodi, Manikandan, Sagar, Tenali G.

“…Background Fosaprepitant is a neurokinin‐1 receptor antagonist, approved for the prevention of chemotherapy‐induced nausea and vomiting. The data on the use of…”
Get full text

Factors that impact the outcomes in testicular germ cell tumors in low–middle-income countries by Saju, S. V., Radhakrishnan, Venkatraman, Ganesan, Trivadi S., Dhanushkodi, Manikandan, Raja, Anand, Selvaluxmy, Ganesarajah, Sagar, Tenali Gnana

“…Germ cell tumors (GCTs) are one of the most common tumors in adolescents and young adults. There is paucity of data on GCT from low–middle-income countries…”
Get full text

Locally Advanced Breast Cancer (LABC): Real-World Outcome of Patients From Cancer Institute, Chennai by Dhanushkodi, Manikandan, Sridevi, Velusamy, Shanta, Viswanathan, Rama, Ranganathan, Swaminathan, Rajaraman, Selvaluxmy, Ganesarajah, Ganesan, Trivadi S.

“…PURPOSE There are sparse data on the outcome of patients with locally advanced breast cancer (LABC). This report is on the prognostic factors and long-term…”
Get full text

The continuing conundrum in oligometastatic breast carcinoma: A real-world data by Selvarajan, Gangothri, Dhanushkodi, Manikandan, Radhakrishnan, Venkatraman, Kalaiyarasi, Jayachandran Perumal, Murali, Carthikeyan Subramaniam, Ananthi, Balasubramanian, Iyer, Priya, Krishnamurthy, Arvind, Velusamy, Sridevi, Ganesarajah, Selvaluxmy, Sagar, Tenali Gnana

“…The optimal management in Oligometastatic (OM) breast carcinoma is not defined. To identify the prognostic factors influencing OM and the effect of…”
Get full text

Study of pathological complete response rate with neoadjuvant concurrent chemoradiation with paclitaxel in locally advanced breast cancer by Iyer, Priya, Radhakrishnan, Venkatraman, Balasubramanian, Ananthi, Sridevi, V, Krishnamurthy, Arvind, Dhanushkodi, Manikandan, Sundersingh, Shirley, Ganesarajah, Selvaluxmy

“…Background: Neoadjuvant concurrent chemoradiation (CTRT) is not widely practiced in breast cancers. The current study presents our experience with the use of…”
Get full text

Metaplastic carcinoma of the breast: real-world outcome from a tertiary cancer centre in India by Balasubramanian, Ananthi, Iyer, Priya, Ranganathan, Rama, Murhekar, Kanchan, Dhanushkodi, Manikandan, Ganesarajah, Selvaluxmy, Velusami, Sridevi, Krishnamurthy, Arvind

“…Metaplastic carcinoma (MPC) is a rare subgroup of breast tumours accounting for <5% of all invasive breast cancers. Histologically confirmed 40 MPC from…”
Get full text

Gastrointestinal Stromal Tumours (GIST): Indian Experience of Rare Malignancy by Malik, Kanuj, Seshadri, Ramakrishnan A., Sundersingh, Shirley, Dhanushkodi, Manikandan

“…GISTs are rare tumours of the GI tract arising from the intestinal cells of Cajal. Though various risk stratification systems have been proposed, none has been…”
Get full text

A modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin by Mehra, Nikita, Christopher, Vasanth, Dhanushkodi, Manikandan, Radhakrishnan, Venkatraman, Ganesan, Trivadi S, Ganesharajah, Selvaluxmy, Sagar, Tenali Gnana, Ganesan, Prasanth

“…Background There is limited data on specific antiemetic protocols for control of chemotherapy-induced nausea/vomiting (CINV) caused by weekly cisplatin…”
Get full text

Perioperative versus postoperative chemotherapy for gastric cancer: A propensity score matched analysis by Kumar, Surendra, Seshadri, Ramakrishnan Ayloor, Trivadi, S. Ganesan, Dhanushkodi, Manikandan, Ellusamy, Hemanth Raj

“…Aim In advanced gastric cancer, chemotherapy, given either perioperatively or as an adjuvant treatment, has been shown to improve survival when compared to…”
Get full text

Prognostic Factors and Outcomes of Early-Stage Hodgkin’s Lymphoma: Multi-Institutional Data From South India by Singuluri, Lakshmi Sandhya, Jayachandran, Perumal Kalaiyarasi, Goenka, Luxitaa, Shenoy, Praveen Kumar, Rathnam, Krishna Kumar, Seshachalam, Arun, Mehra, Nikita, Kumar, Mummoorthy Ram, Suseela, Murugan Mangai, Raghavan, Vineetha, Nair, Chandran K., Dubashi, Biswajit, Dhanushkodi, Manikandan, Ganesan, Prasanth

“…Early-stage Hodgkin's lymphoma (ESHL) is highly curable, usually with a combination of chemotherapy and radiation. Real-world data may show differences in…”
Get full text